What is Computer Vision in Healthcare Market?
The computer vision in healthcare diagnosis provides high levels of precision by minimizing errors. It allows detection of the minimal presence of a condition that may be missed by doctors because of their human limitations. Currently, Several areas in healthcare using computer vision and benefiting medical professionals to better diagnose patients, including medical imaging analysis, health monitoring, predictive analysis, among others. The benefits of computer vision technology can assist health systems. Increasing government initiatives to increase the adoption of AI-based technologies and rising big data in healthcare drives the global computer vision in the healthcare market.
Highlights from Computer Vision in Healthcare Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | NVIDIA Corporation (United States), Microsoft (United States), Intel Corporation (United States), Xilinx Inc. (United States), IBM (United States), Google (United States), Basler AG (Germany), Arterys (United States), AiCure (United States) and iCAD Inc. (United States) |
There are various companies are operating in this industry and heavily conducting research on the characteristics of software and how will provide more innovative product designing. There are various market players are entering this industry to capture market growth opportunities. The market leaders are investing in organic and non-organic strategic growth initiatives to become dominant in this industry. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Computer Vision in Healthcare market throughout the forecasted period.
NVIDIA Corporation (United States), Microsoft (United States), Intel Corporation (United States), Xilinx Inc. (United States), IBM (United States), Google (United States), Basler AG (Germany), Arterys (United States), AiCure (United States) and iCAD Inc. (United States) are some of the key players profiled in the study. Computer Vision in Healthcare Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Medical Imaging and Diagnostics, Surgeries and Other Applications (Clinical Trials, Patient Management, and Research) |
Type | Hardware (Processors (CPUs, GPUs, FPGAs, ASICs, VPUs), Memory Devices, Networks), Software (Cloud-based, On-premise) and Services |
End User | Healthcare Providers,Diagnostic Centers,Other End Users (Academic Research Institutes |
On the basis of geography, the market of Computer Vision in Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Cloud-Based Healthcare Computer Vision Solutions
Market Growth Drivers:
Government Initiatives to Increase the Adoption of AI-based Technologies, Big Data in Healthcare and Use of Computer Vision in Precision Medicine
Challenges:
Rising Security Concerns Related to Cloud-Based Image Processing and Analytics and Lack of Curated Data
Restraints:
Lack of Awareness and Technical Knowledge
Opportunities:
Growth Opportunities in Developing Countries and Advancements in Application Delivery and Software-Defined Age
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Computer Vision in Healthcare Provider, Government Regulatory and Research Organizations and End-Use Industries
Market Leaders & Development Strategies
In May 2018, Intel collaborates with Novartis* on the use of deep neural networks (DNN) to accelerate high content screening – a key element of early drug discovery.
In Oct 2018, IBM announced that it plans to incorporate the new RAPIDS™ open source software into its enterprise-grade data science platform for on-premises, hybrid, and multi-cloud environments. With IBM's vast portfolio of deep learning and machine learning solutions, it is best positioned to bring this open-source technology to data scientists regardless of their preferred deployment model.